The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep35770.pdf
Reference39 articles.
1. Dela Cruz, C. S., Tanoue, L. T. & Matthay, R. A. Lung cancer: epidemiology, etiology, and prevention. Clinics in chest medicine 32, 605–644 (2011).
2. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108 (2015).
3. Travis, W. D. et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 10, 1243–1260 (2015).
4. Khanal, N. & Ganti, A. K. Emerging targeted therapies in non-small cell lung cancer. Expert review of anticancer therapy 16, 177–187 (2016).
5. Minuti, G., D’Incecco, A., Landi, L. & Cappuzzo, F. Protein kinase inhibitors to treat non-small-cell lung cancer. Expert opinion on pharmacotherapy 15, 1203–1213 (2014).
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cyclohexane-1,3-dione Derivatives as Future Therapeutic Agents for NSCLC: QSAR Modeling, In Silico ADME-Tox Properties, and Structure-Based Drug Designing Approach;ACS Omega;2023-01-19
2. MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis;Frontiers in Oncology;2022-10-27
3. The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences;Critical Reviews in Oncology/Hematology;2022-04
4. Capmatinib-Induced Pseudo–Acute Kidney Injury: A Case Report;American Journal of Kidney Diseases;2022-01
5. MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer;Cancers;2021-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3